The Institute of Cancer Research has led a study showing that chromosomal instability in circulating tumour cells can predict resistance to cabazitaxel in men with advanced prostate cancer. Using ...
The transaction builds on an established partnership between the EBRD and BOSQAR, which has resulted in up to €150 million in equity and bond financing to date. More broadly, the EBRD has invested ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback